These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26344911)

  • 41. Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors.
    Shen FQ; Shi L; Wang ZF; Wang CR; Chen JJ; Liu Y; Qiu HY; Zhu HL
    Bioorg Med Chem; 2019 Sep; 27(17):3813-3824. PubMed ID: 31327679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
    Huang Z; Zhao B; Qin Z; Li Y; Wang T; Zhou W; Zheng J; Yang S; Shi Y; Fan Y; Xiang R
    Eur J Med Chem; 2019 Nov; 181():111541. PubMed ID: 31382120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1,2,4-Triazolin-5-thione derivatives with anticancer activity as CK1γ kinase inhibitors.
    Pitucha M; Janeczko M; Klimek K; Fornal E; Wos M; Pachuta-Stec A; Ginalska G; Kaczor AA
    Bioorg Chem; 2020 Jun; 99():103806. PubMed ID: 32279038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors.
    Song D; Park Y; Yoon J; Aman W; Hah JM; Ryu JS
    Bioorg Med Chem; 2014 Sep; 22(17):4855-66. PubMed ID: 25042560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of novel 2-alkyl triazole-3-alkyl substituted quinoline derivatives and their cytotoxic activity.
    Sambasiva Rao P; Kurumurthy C; Veeraswamy B; Santhosh Kumar G; Shanthan Rao P; Pamanji R; Venkateswara Rao J; Narsaiah B
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1225-7. PubMed ID: 23352638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.
    Hou W; Luo Z; Zhang G; Cao D; Li D; Ruan H; Ruan BH; Su L; Xu H
    Eur J Med Chem; 2017 Sep; 138():1042-1052. PubMed ID: 28759877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation.
    Gregorić T; Sedić M; Grbčić P; Tomljenović Paravić A; Kraljević Pavelić S; Cetina M; Vianello R; Raić-Malić S
    Eur J Med Chem; 2017 Jan; 125():1247-1267. PubMed ID: 27875779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid synthesis of triazole-modified resveratrol analogues via click chemistry.
    Pagliai F; Pirali T; Del Grosso E; Di Brisco R; Tron GC; Sorba G; Genazzani AA
    J Med Chem; 2006 Jan; 49(2):467-70. PubMed ID: 16420033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids.
    Pham Thi T; Le Nhat TG; Ngo Hanh T; Luc Quang T; Pham The C; Dang Thi TA; Nguyen HT; Nguyen TH; Hoang Thi P; Van Nguyen T
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3652-7. PubMed ID: 27342752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer.
    Nafie MS; Boraei ATA
    Bioorg Chem; 2022 May; 122():105708. PubMed ID: 35290929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Click chemistry-assisted synthesis of novel aminonaphthoquinone-1,2,3-triazole hybrids and investigation of their cytotoxicity and cancer cell cycle alterations.
    Gholampour M; Ranjbar S; Edraki N; Mohabbati M; Firuzi O; Khoshneviszadeh M
    Bioorg Chem; 2019 Jul; 88():102967. PubMed ID: 31078767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of 4,6-Disubstituted Pyrimidine Derivatives as Novel Dual VEGFR2/FGFR1 Inhibitors.
    Zhang JY; Xue WJ; Wang M; Li W; Dong R; Li MT; Sun LP
    Chem Biodivers; 2021 May; 18(5):e2100095. PubMed ID: 33829649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives.
    Hirose M; Okaniwa M; Miyazaki T; Imada T; Ohashi T; Tanaka Y; Arita T; Yabuki M; Kawamoto T; Tsutsumi S; Sumita A; Takagi T; Sang BC; Yano J; Aertgeerts K; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2012 Sep; 20(18):5600-15. PubMed ID: 22883026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of new 4-alkoxyquinazoline-based derivatives as potent VEGFR2 inhibitors.
    Yin Y; Sha S; Wang YT; Wu X; Wang SF; Qiao F; Lv PC; Zhu HL
    Chem Biol Drug Des; 2015 Nov; 86(5):1323-9. PubMed ID: 26032487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and Rational Design of New Appended 1,2,3-Triazole-uracil Ensembles as Promising Anti-Tumor Agents via In Silico VEGFR-2 Transferase Inhibition.
    Reddy NN; Hung SJ; Swamy MK; Sanjeev A; Rao VS; Rohini R; Raju AK; Bhaskar K; Hu A; Reddy PM
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33808444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Click chemistry inspired synthesis and bioevaluation of novel triazolyl derivatives of osthol as potent cytotoxic agents.
    Farooq S; Shakeel-u-Rehman ; Hussain A; Hamid A; Qurishi MA; Koul S
    Eur J Med Chem; 2014 Sep; 84():545-54. PubMed ID: 25062005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents.
    Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
    Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
    Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
    Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.